Nureca IPO Review 2021: The Nureca IPO opens on 15th Feb and closes on 17th Feb 2021. In this article, we cover the Nureca IPO Review and look into important IPO information and find out the possible prospects of the company. Let’s get started. 

Nureca IPO Review – About the Company 

Nureca IPO Review - About the Company 

Founded in 2016, Nureca Ltd. is engaged in the distribution of healthcare and wellness products. Nureca which sells its products through the brand – Dr. Trust, Trumom, and Dr. Physio, was the first company to sell such products online through its website dr.trust.in.

The company aims to offer the best Premium quality healthcare and wellness products. It also believes in innovation and catering new products to the ever-growing Indian healthcare needs.

Zerodha demat account

Nureca IPO Review - About the Company 

Nureca has a diverse product line that includes:

  • Chronic Device Products – blood pressure monitors, pulse oximeters, thermometers, nebulizers, self-monitoring glucose devices, humidifiers, and steamers.
  • Orthopedic Products – wheelchairs, walkers, lumbar and tailbone supports, and physiotherapy electric massagers.
  • Mother and Child Products – breast pumps, bottle sterilizers, bottle warmers, car seats, and baby carrycots.
  • Nutrition Supplements – fish oil, multivitamins, probiotics, biotin, apple cider, and vinegar.
  • Lifestyle Products – smart scales, aroma diffusers, and fitness tracker.

Dr trust Nureca

Over the years the company has built a strong online presence and uses this channel to sell its products to retailers, and other distributor and retail players. The company also sells its products directly to consumers through its website.

In 2019, Nureca partnered with Tata Group’s Croma to become the first company to sell healthcare and wellness products in their retail stores. Its current market includes India and its neighboring countries.

Nureca IPO Review financials

Abhay Doshi, the founder of UnlistedArena.com associated the impressive growth in sales in the first six months of FY21 to the fear of the COVID-19 pandemic and patients avoiding visiting hospitals and clinics which led to an increase in sales. He also stated that as the situation normalizes the growth trajectory will return to its previous growth trajectory.

The health market in India and its neighboring countries stood at Rs.20,757 crore in 2019 and is expected to grow to Rs.38,920 crore by 2025 at a CAGR of 11.0%.  This growth will be driven by rising awareness of Health and wellness, increasing spending power, the growing burden of chronic diseases, and the need for Healthcare stakeholders to reduce healthcare costs.

Nureca IPO Review financials

Nureca IPO Review – Key IPO Information

Saurabh Goyal is the promoter of the company. It has appointed ITI Capital as the sole book-running lead manager to the issue. 

5Paisa Astronaut Ad

Important Nureca Ltd. IPO details

ParticularDetails
IPO Size₹100.00 Cr
Offer For Sale(OFS)-
Opening DateFeb 15, 2021
Closing DateFeb 17, 2021
Face Value₹10 per equity share
Price Band₹396 to ₹400 per equity share
Lot Size35 Shares
Minimum Lot Size1(35 shares - ₹14,000)
Maximum Lot Size14 (490 shares- ₹196,000)

Nureca Ltd IPO Review – Purpose of the IPO

The IPO proceeds will be utilized for the following purposes:

  • To meet the working capital requirements of the business.
  • To meet general corporate purposes.

The company also expects to enhance its visibility and brand image among existing and potential customers through the IPO

Closing Thoughts

Nureca Ltd that sells its products through the brand – Dr. Trust, Trumom, and Dr. Physio, aims to offer the best Premium quality healthcare and wellness products. The IPO opens on 15th Feb and closes on 17th Feb 2021. For retail investors, it can be a good opportunity to look into the company’s future prospects and apply for the IPO if they believe in the products and services offered by Nureca.

That’s all for this post. Do let us know what do you think of Nureca Ltd IPO Review. Are you planning to apply for this IPO or not? Comment below. Cheers!